[Calcium dobesilate].
D000328:Adult; D000368:Aged; D000818:Animals; D001557:Benzenesulfonates / Q000627:therapeutic use*; D002123:Calcium Dobesilate / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003925:Diabetic Angiopathies / Q000188:drug therapy; D003930:Diabetic Retinopathy / Q000188:drug therapy; D005260:Female; D006801:Humans; D007928:Lethal Dose 50; D051379:Mice; D008875:Middle Aged; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D013997:Time Factors; D014648:Varicose Veins / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy; D014689:Venous Insufficiency / Q000188:drug therapy
D001557:Benzenesulfonates; D002123:Calcium Dobesilate
Calciumdobesilat